CareMax, Inc. Appoints Beatriz Assapimonwait to Board of Directors
20 Septiembre 2021 - 5:55AM
Business Wire
CareMax, Inc. (“CareMax”) (NASDAQ: CMAX; CMAXW), a leading
technology-enabled provider of value-based care to seniors, today
announced that Beatriz Assapimonwait has been appointed as an
independent member of the CareMax board of directors.
Ms. Assapimonwait brings to CareMax 38 years of Medicare managed
care experience, including a decade of experience as a leader in
the Medicare markets in South Florida, North Florida, and Puerto
Rico. Most recently, Ms. Assapimonwait served as the Regional
President for Humana South Florida where she was responsible for
developing market strategies and leading market operations. Before
that, Ms. Assapimonwait was CEO of Family Physicians of Winter
Park, an MSO serving over 40,000 patients at 22 offices, and has
held senior positions at Aetna and InnovaCare Health Solutions.
“We are excited to welcome Ms. Assapimonwait to CareMax as a
member of our board,” said Carlos de Solo, CEO of CareMax. “She
brings a valuable perspective to this role given her rich and
diverse background, including extensive managed care expertise with
a track record of success in healthcare operations, finance,
contracting, legislative and regulatory implementation, and sales
and marketing.”
“CareMax is recognized as a trusted provider of value-based
healthcare that delivers proven results,” said Ms. Assapimonwait.
“I look forward to supporting the Company’s mission to optimize
patient outcomes, broaden access to quality whole person
healthcare, and reduce unnecessary costs.”
About CareMax
CareMax is a technology-enabled care platform providing
value-based care and chronic disease management to seniors. CareMax
operates medical centers that offer a comprehensive suite of
healthcare and social services, and a proprietary software and
services platform that provides data, analytics, and rules-based
decision tools/workflows for physicians across the United States.
Learn more at www.caremax.com.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended, Section 21E of the Securities Exchange Act of 1934, as
amended, and the Private Securities Litigation Reform Act of 1995,
as amended. These forward-looking statements include statements
regarding our future growth and strategy. Words such as
“anticipate,” “believe,” “budget,” “contemplate,” “continue,”
“could,” “envision,” “estimate,” “expect,” “guidance,” “indicate,”
“intend,” “may,” “might,” “plan,” “possibly,” “potential,”
“predict,” “probably,” “pro-forma,” “project,” “seek,” “should,”
“target,” or “will,” or the negative or other variations thereof,
and similar words or phrases or comparable terminology, are
intended to identify forward-looking statements. These
forward-looking statements reflect the Company’s expectations,
plans or forecasts of future events and views as of the date of
this press release. These forward-looking statements are not
guarantees of future performance, conditions or results, and
involve a number of known and unknown risks, uncertainties,
assumptions and other important factors, many of which are outside
the Company’s control, that could cause actual results or outcomes
to differ materially from those discussed in the forward-looking
statements.
Important risks and uncertainties that could cause the Company’s
actual results and financial condition to differ materially from
those indicated in forward-looking statements include, among
others, the impact of COVID-19 or any variant thereof on the
Company’s business and results of operation; the availability of
sites for medical facilities and the costs of opening such medical
facilities; changes in market or industry conditions, regulatory
environment, competitive conditions, and receptivity to the
Company’s services; the Company’s ability to continue its growth,
including in new markets; changes in laws and regulations
applicable to the Company’s business, in particular with respect to
Medicare Advantage and Medicaid; the Company’s ability to maintain
its relationships with health plans and other key payers; any
delay, modification or cancellation of government contracts; the
Company’s future capital requirements and sources and uses of cash,
including funds to satisfy its liquidity needs; the Company or any
other party’s ability to fulfill contractual obligations; and the
Company’s ability to recruit and retain qualified team members and
independent physicians. For a detailed discussion of the risk
factors that could affect the Company’s actual results, please
refer to the risk factors identified in the Company’s reports filed
with the SEC. All information provided in this press release is as
of the date hereof, and the Company undertakes no duty to update or
revise this information unless required by law, and forward-looking
statements should not be relied upon as representing the Company’s
assessments as of any date subsequent to the date of this press
release.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210920005262/en/
CareMax, Inc. Media
Christine Bucan (305) 542-8855 Christine@thinkbsg.com Investor
Relations Ben Quirk (415) 640-3715 ben.quirk@caremax.com The
Equity Group Inc. Devin Sullivan (212) 836-9608
dsullivan@equityny.com
CareMax (NASDAQ:CMAXW)
Gráfica de Acción Histórica
De Ago 2024 a Sep 2024
CareMax (NASDAQ:CMAXW)
Gráfica de Acción Histórica
De Sep 2023 a Sep 2024